Health Condition 1: M179- Osteoarthritis of knee, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants having pain in one or both knee joints since more than three months Average severity of knee pain in the past week is reported more than four when assessed through Wong-Baker Faces Participants scoring more than three in the Mini-Cog scale Diagnosed cases of Knee osteoarthritis (OA) or those who fulfil the clinical American College of Rheumatology (ACR) criteria for knee osteoarthritis Able to give written informed consent
Exclusion criteria
Exclusion criteria: Non-ambulatory patients Participants showing severe osteoarthritis on radiological evaluation and eligible to be categorized as Grade-4 of Kellgren and Lawrence scale for OA (Antero-posterior X-Ray of the affected knee showing large osteophytes, marked narrowing of joint space, severe sclerosis and definite deformity of bone ends) History of treatment with intra-articular injection of corticosteroids or hyaluronic acid or oral corticosteroids within a period of three months preceding study Patients on regular intake of Ayurveda medicines (including any Ayurveda procedures) or physiotherapy (including therapeutic exercises) for pain relief in the past 2 weeks Patients having unilateral/bilateral fixed flexion deformity in knees or metallic implant in knee joint; or severe deformity of lower limbs (e.g., knee varus or knee valgus) History of knee joint replacement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in score of Numeric Pain Rating ScaleTimepoint: Baseline; at the end of Week 2, Week 4 and Week 6 | — |
Secondary
| Measure | Time frame |
|---|---|
| KOOS range of motion of the affected knee joint(s) TUG FTSST Wellbeing Index GSAQ Comparison of frequency of use of conventional analgesic medicines as rescue medication for symptomatic relief in knee pain during the study period, with baseline and between the groups Comparison of incidence of treatment emergent adverse events (like skin irritation, weight gain, gastric reactions, changes in vitals like blood pressure etc.) in both groupsTimepoint: Baseline and at the end of six weeks | — |
Countries
India
Contacts
MGAC, DMIMS